Results 231 to 240 of about 375,473 (301)

Early parent‐child interaction and home environments of children exposed prenatally to opioids: A comparison of biological mothers and out‐of‐home caregivers

Infant Mental Health Journal: Infancy and Early Childhood, Volume 46, Issue 3, Page 343-358, May 2025.
Abstract Children born to mothers with opioid use disorder (OUD) are at increased risk of maltreatment and out‐of‐home care (OOHC) placement. This study examines the parent‐child interaction quality and home environments of 92 New Zealand children with prenatal opioid exposure (OE) and 106 non‐opioid‐exposed (NE) children.
Samantha J. Lee, Alison Davie‐Gray, Lianne J. Woodward   +2 more
wiley   +1 more source

Current drug use patterns and HIV and HCV prevalence among people who inject drugs in suburban areas of Malaysia

Journal of the International AIDS Society, Volume 28, Issue 5, May 2025.
Abstract Introduction National surveillance data in Malaysia has observed a marked reduction in the number of new HIV cases among people who inject drugs (PWID) in the past decade. This study sought to estimate the current prevalence and associated risk factors of HIV and hepatitis C virus (HCV) among PWID in suburban areas of Klang Valley, Malaysia ...
Joselyn Pang, Mahmoud Danaee, Vicknasingam Balasingam Kasinather, Don Des Jarlais, Adeeba Kamarulzaman, NA Mohd Salleh   +5 more
wiley   +1 more source

GABAB Receptor: Structure, Biological Functions, and Therapy for Diseases

MedComm, Volume 6, Issue 5, May 2025.
Within the GABAergic system, GABABRs are potential therapeutic targets for dealing multiple metabolic and binge eating disorders and food addiction. Allosteric modulators and small peptides targeting GABABR signaling pathways may be developed as attractive drug candidates that avoid the side effects of agents that directly bind these receptors ...
Weijie Xie, Yuan Li, Xinyue Wang, Elena Blokhina, Evgeny Krupitsky, Marina Vetrova, Ji Hu, Ti‐Fei Yuan, Jue Chen, Hua Wang, Xiangfang Chen   +10 more
wiley   +1 more source

Efficacy of cannabidiol alone or in combination with Δ‐9‐tetrahydrocannabinol for the management of substance use disorders: An umbrella review of the evidence

Addiction, Volume 120, Issue 5, Page 813-834, May 2025.
Abstract Background and Aims Substance use disorders (SUD) lead to a high burden of disease, yet treatment options are limited. Cannabidiol (CBD) is being investigated as a potential therapeutic target due to its pharmacological properties and mode of action in the endocannabinoid system.
Bertrand Redonnet, Filiz Eren, Guillaume Avenin, Maria Melchior, Murielle Mary‐Krause   +4 more
wiley   +1 more source

Sleep disturbance and its associations with severity of dependence, depression and quality of life among heroin-dependent patients: a cross-sectional descriptive study [PDF]

, 2017
Vincent Chin‐Hung Chen, Hua Ting, Meng-Huan Wu, Tsang‐Yaw Lin, Michael Gossop   +4 more
openalex   +1 more source

'Loss of control' in alcoholism and drug addiction:A neuroscientific interpretation [PDF]

, 2000
Lyvers, M.
core   +1 more source

Is methamphetamine blood concentration in emergency department patients associated with the clinical picture?

Addiction, Volume 120, Issue 5, Page 1007-1015, May 2025.
Abstract Aims This study aimed to describe clinical features and outcomes of patients presenting to the emergency department with analytically confirmed methamphetamine intoxication, to determine the blood concentration of methamphetamine and to test its association with clinical findings.
David McCutcheon, Jessamine Soderstrom, Mohan Raghavan, Francois Oosthuizen, Bianca Douglas, Sally Burrows, Jennifer L. Smith, Daniel Fatovich   +7 more
wiley   +1 more source

Extended‐release pharmacotherapies for substance use disorders in incarcerated populations: A systematic review

Addiction, Volume 120, Issue 5, Page 835-859, May 2025.
Abstract Background and aims Substance use (SU) is prevalent among individuals in the criminal justice system (CJS). However, there is often poor access to treatment. We aimed to assess the effectiveness of two medications, extended‐release naltrexone (XR‐NTX) and extended‐release buprenorphine (XR‐BUP) for the prison population.
Amelia Woods, Catherine Foley, Katherine M. Conigrave, Winifred Asare‐Doku, Anthony Shakeshaft, Stella Settumba‐Stolk, Michael Farrell, Michael Doyle   +7 more
wiley   +1 more source

Case series: Symptom‐inhibited fentanyl induction (SIFI) onto treatment‐dose opioid agonist therapy in a community setting

The American Journal on Addictions, Volume 34, Issue 3, Page 355-360, May 2025.
Abstract Background and Objectives Existing opioid agonist therapy (OAT) guidelines are far from sufficient to address rising opioid tolerances and potency of the unregulated opioid market in North America. Inadequate starting doses of OAT are a universally recognized barrier for people who use fentanyl.
Pouya Azar, Jane J. Kim, Ruth Davison, Zoran Barazanci, Martha J. Ignaszewski, James S. H. Wong, Jessica Machado, Marianne Harris, Michael Krausz, Nickie Mathew, Andrew Herring, Julio S. G. Montaner   +11 more
wiley   +1 more source

Cannabis Legalization and its Effects on Organized Crime: Lessons and Research Recommendations from Canada

Sociological Inquiry, Volume 95, Issue 2, Page 394-414, May 2025.
In October 2018, Canada legalized and regulated its entire recreational cannabis supply chain via the Cannabis Act. One of the objectives of this new policy was to take revenue away from organized crime groups. Five years after the Cannabis Act went into effect, we address the following question: what do we know about the impacts of cannabis regulation
Martin Bouchard, Naomi Zakimi, Benoît Gomis   +2 more
wiley   +1 more source